Bioventus Inc. Income Tax Expense (Benefit) in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bioventus Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to Q3 2025.
  • Bioventus Inc. Income Tax Expense (Benefit) for the quarter ending September 27, 2025 was $664K, a 12.7% increase year-over-year.
  • Bioventus Inc. Income Tax Expense (Benefit) for the twelve months ending September 27, 2025 was $2.16M.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2024 was -$5.29M, a 6327% decline from 2023.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2023 was $85K.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2022 was -$44.4M, a 2157% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Bioventus Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.16M $664K +$75K +12.7% Jun 29, 2025 Sep 27, 2025 10-Q 2025-11-04
Q2 2025 $2.09M $1.04M +$8.38M Mar 30, 2025 Jun 28, 2025 10-Q 2025-08-06
Q1 2025 -$6.3M -$95K -$1M -110% Jan 1, 2025 Mar 29, 2025 10-Q 2025-05-06
Q4 2024 -$5.29M $550K +$1.3M Sep 29, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 -$6.59M $589K -$11K -1.83% Jun 30, 2024 Sep 28, 2024 10-Q 2025-11-04
Q2 2024 -$6.58M -$7.34M -$7.72M -2026% Mar 31, 2024 Jun 29, 2024 10-Q 2025-08-06
Q1 2024 $1.14M $907K +$1.05M Jan 1, 2024 Mar 30, 2024 10-Q 2025-05-06
Q4 2023 $85K -$750K +$10.2M +93.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 -$10.1M $600K +$30.1M Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$40.3M $381K -$863K -69.4% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 -$39.4M -$146K +$4.99M +97.2% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 -$44.4M -$11M -$8.24M -302% Oct 2, 2022 Dec 31, 2022 10-K 2025-03-11
Q3 2022 -$36.1M -$29.5M -$28.6M -3247% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 -$7.5M $1.24M -$470K -27.4% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 -$7.03M -$5.13M -$5.06M -6930% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q4 2021 -$1.97M -$2.73M -$3.62M -406% Oct 3, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 $1.65M -$882K -$1.26M -336% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-21
Q2 2021 $2.9M $1.71M +$1.82M Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-12
Q1 2021 $1.08M -$73K -$112K -287% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $1.19M $890K Sep 27, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $373K Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 -$110K Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $39K Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-13

Bioventus Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5.29M -$5.38M -6327% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $85K +$44.5M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$44.4M -$42.4M -2157% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-11
2021 -$1.97M -$3.16M -265% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $1.19M -$384K -24.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $1.58M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.